Is a complete INKT research report available?

No complete published report is available for MiNK Therapeutics, Inc. (INKT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MiNK Therapeutics, Inc. (INKT)

NASDAQ: INKT · USD

$10.8

+0.13 (+1.2%)· Recorded snapshot

Market cap	54.9M
Net income (ttm)	-11.4M
EPS (ttm)	-$2.40
Shares out	5.1M
Volume	6,081
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.4M
EPS (ttm): -$2.40
Market cap: 54.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001840229
Company name	MiNK Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	603693201
Earnings date	2026-11-13
Earnings time	bmo
Employees	15
Employees change	-8
Employees growth	-34.78%
Enterprise value	$46.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2021-10-15
Is primary listing	Yes
Is SPAC	No
ISIN number	US6036932019
Last 10-K release date	2026-03-31
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2025-01-28
Last stock split type	Reverse
Market cap	$54.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-13
Options	No
Price	$10.76
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	INKT
U.S. state	New York
Website	https://minktherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001840229

Company name

MiNK Therapeutics, Inc.

Country

United States

Country code

CUSIP number

603693201

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

-8

Employees growth

-34.78%

Enterprise value

$46.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2021-10-15

Is primary listing

Yes

Is SPAC

ISIN number

US6036932019

Last 10-K release date

2026-03-31

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2025-01-28

Last stock split type

Reverse

Market cap

$54.9M

Market cap category

Micro-Cap

Next earnings date

2026-11-13

Options

Price

$10.76

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

INKT

U.S. state

New York

Website

https://minktherapeutics.com

Metric	Value
Earnings yield	-22.28%
FCF / EV yield	-15.03%
FCF yield	-12.59%
Forward EV/Sales	23.91x
Forward P/S	28.55x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-22.28%

FCF / EV yield

-15.03%

FCF yield

-12.59%

Forward EV/Sales

23.91x

Forward P/S

28.55x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-757,359
ROA	-123.84%
ROA (5Y)	-88.25%
ROCE	-585.77%

Metric

Value

Profit per employee

$-757,359

ROA

-123.84%

ROA (5Y)

-88.25%

ROCE

-585.77%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$154,347
EBIT	$-12M
EBITDA	$-11.8M
EPS	$-2.40
FCF per share	$-1.34
Financing cash flow	$14M
Free cash flow	$-6.8M
Free cash flow minus SBC	$-9.1M
Net borrowing	$-5M
Net cash flow	$7.1M
Net income	$-11.4M
Operating cash flow minus SBC	$-9.1M
Operating income	$-12M
Stock-based compensation	$2.2M

Metric

Value

Depreciation and amortization

$154,347

EBIT

$-12M

EBITDA

$-11.8M

EPS

$-2.40

FCF per share

$-1.34

Financing cash flow

$14M

Free cash flow

$-6.8M

Free cash flow minus SBC

$-9.1M

Net borrowing

$-5M

Net cash flow

$7.1M

Net income

$-11.4M

Operating cash flow minus SBC

$-9.1M

Operating income

$-12M

Stock-based compensation

$2.2M

Metric	Value
Book value per share	$-2.75
Long-term assets	$318,474
Long-term liabilities	$16.1M
Net cash (debt)	$8.8M
Net cash / market cap	16.24%
Piotroski F-Score	2
Property, plant and equipment	$318,474
Shareholders' equity	$-14M
Tangible book value	$-14M
Tangible book value per share	$-2.75
Total assets	$9.6M
Total cash	$8.8M
Total debt	$0
Total liabilities	$23.6M
WACC	6.85%

Metric

Value

Book value per share

$-2.75

Long-term assets

$318,474

Long-term liabilities

$16.1M

Net cash (debt)

$8.8M

Net cash / market cap

16.24%

Piotroski F-Score

Property, plant and equipment

$318,474

Shareholders' equity

$-14M

Tangible book value

$-14M

Tangible book value per share

$-2.75

Total assets

$9.6M

Total cash

$8.8M

Total debt

Total liabilities

$23.6M

WACC

6.85%

Metric	Value
Current assets	$9.3M
Current liabilities	$7.6M
Current ratio	1.23
Net working capital	$-7.1M
Quick ratio	1.16
Working capital	$1.7M

Metric

Value

Current assets

$9.3M

Current liabilities

$7.6M

Current ratio

1.23

Net working capital

$-7.1M

Quick ratio

1.16

Working capital

$1.7M

Metric	Value
Buyback yield / dilution	-19.52%
Dividend yield	0%
Shareholder yield	-19.52%

Metric

Value

Buyback yield / dilution

-19.52%

Dividend yield

Shareholder yield

-19.52%

Metric	Value
150-day SMA	$11.38
1D price change	1.22%
1M price change	-12.56%
1M total return	-12.56%
1W price change	8.01%
1W total return	8.01%
1Y price change	-26.75%
1Y return CAGR	-26.77%
1Y total return	-26.75%
20-day SMA	$10.76
200-day SMA	$11.30
3M price change	0.57%
3M total return	0.57%
3Y price change	16.97%
3Y return CAGR	5.36%
3Y total return	16.97%
50-day SMA	$11.38
50-day SMA vs 200-day SMA	50over200
52-week high	$16.93
52-week high date	2026-03-10
52-week low	$8.48
52-week low date	2026-03-24
5Y price change	-92.15%
5Y return CAGR	-39.88%
5Y total return	-92.15%
6M price change	-4.4%
6M total return	-4.4%
All-time high	$221.55
All-time high date	2021-11-01
All-time low	$4.56
All-time low date	2025-01-28
Average true range (ATR)	$0.71
Average volume	17.2K
Beta (1Y)	1.45
Beta (2Y)	0.11
Beta (5Y)	0.47
Change from 52-week high	-36.43%
Change from 52-week low	26.89%
Change from all-time high	-95.19%
Change from all-time low	133.55%
Change from open	0%
Day's gap	1.22%
Dollar volume	$65,432
High price	$10.76
Low price	$10.76
Monthly RSI	36.38
Open price	$10.76
Premarket change	3.48%
Premarket close	$10.63
Premarket price	$11.00
Previous close	$10.63
Price vs 150-day SMA	-6.39%
Price vs 20-day SMA	-1.01%
Price vs 200-day SMA	-5.76%
Price vs 50-day SMA	-6.38%
Relative volume	0.35
Return from IPO open	-91.17%
Return from IPO price	-11.42%
RSI	47.5
Sharpe ratio	-0.13
Sharpe ratio (3Y)	0.5
Sharpe ratio (5Y)	0.33
Sortino ratio	-0.12
Sortino ratio (3Y)	3.5
Sortino ratio (5Y)	1.64
Volume	6.1K
Weekly RSI	46.43
YTD price change	-4.48%
YTD total return	-4.48%

Metric

Value

150-day SMA

$11.38

1D price change

1.22%

1M price change

-12.56%

1M total return

-12.56%

1W price change

8.01%

1W total return

8.01%

1Y price change

-26.75%

1Y return CAGR

-26.77%

1Y total return

-26.75%

20-day SMA

$10.76

200-day SMA

$11.30

3M price change

0.57%

3M total return

0.57%

3Y price change

16.97%

3Y return CAGR

5.36%

3Y total return

16.97%

50-day SMA

$11.38

50-day SMA vs 200-day SMA

50over200

52-week high

$16.93

52-week high date

2026-03-10

52-week low

$8.48

52-week low date

2026-03-24

5Y price change

-92.15%

5Y return CAGR

-39.88%

5Y total return

-92.15%

6M price change

-4.4%

6M total return

-4.4%

All-time high

$221.55

All-time high date

2021-11-01

All-time low

$4.56

All-time low date

2025-01-28

Average true range (ATR)

$0.71

Average volume

17.2K

Beta (1Y)

1.45

Beta (2Y)

0.11

Beta (5Y)

0.47

Change from 52-week high

-36.43%

Change from 52-week low

26.89%

Change from all-time high

-95.19%

Change from all-time low

133.55%

Change from open

Day's gap

1.22%

Dollar volume

$65,432

High price

$10.76

Low price

$10.76

Monthly RSI

36.38

Open price

$10.76

Premarket change

3.48%

Premarket close

$10.63

Premarket price

$11.00

Previous close

$10.63

Price vs 150-day SMA

-6.39%

Price vs 20-day SMA

-1.01%

Price vs 200-day SMA

-5.76%

Price vs 50-day SMA

-6.38%

Relative volume

0.35

Return from IPO open

-91.17%

Return from IPO price

-11.42%

RSI

47.5

Sharpe ratio

-0.13

Sharpe ratio (3Y)

0.5

Sharpe ratio (5Y)

0.33

Sortino ratio

-0.12

Sortino ratio (3Y)

3.5

Sortino ratio (5Y)

1.64

Volume

6.1K

Weekly RSI

46.43

YTD price change

-4.48%

YTD total return

-4.48%

Metric	Value
Float	2.1M
Float percentage	40.42%
Shares change (QoQ)	4.7%
Shares change (YoY)	19.52%
Shares held by insiders	16.92%
Shares held by institutions	4%
Shares outstanding	5.1M
Short % of float	2.32%
Short % of shares	0.94%
Short ratio	2.9 days

Metric

Value

Float

2.1M

Float percentage

40.42%

Shares change (QoQ)

4.7%

Shares change (YoY)

19.52%

Shares held by insiders

16.92%

Shares held by institutions

Shares outstanding

5.1M

Short % of float

2.32%

Short % of shares

0.94%

Short ratio

2.9 days

MiNK Therapeutics, Inc. (INKT)

Price

Financial snapshot

Fair-value bridge

Latest news · INKT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INKT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INKT

Frequently asked questions